1270P IMscin001: Phase Ib dose-finding study of subcutaneous atezolizumab in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
Autor: | Burotto, M., Felip, E., Zvirbule, Z., Baranda, L.A. Herraez, Chanu, P., Kshirsagar, S., Maiya, V., Pozzi, E., Restuccia, E. |
---|---|
Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S820-S821 |
Databáze: | ScienceDirect |
Externí odkaz: |